Calcineurin inhibitors for the treatment of skin disease: how do they work?
Hampton
P J
PJ
Reynolds
N J
NJ
D001327:Autoimmune Diseases / Q000188:drug therapy; D065095:Calcineurin Inhibitors; D002908:Chronic Disease; D004268:DNA-Binding Proteins / Q000037:antagonists & inhibitors; D006801:Humans; D008213:Lymphocyte Activation / Q000187:drug effects; D050778:NFATC Transcription Factors; D009687:Nuclear Proteins / Q000037:antagonists & inhibitors; D012871:Skin Diseases / Q000188:drug therapy*; D013601:T-Lymphocytes / Q000187:drug effects; D014157:Transcription Factors / Q000037:antagonists & inhibitors; D014581:Urticaria / Q000188:drug therapy
D065095:Calcineurin Inhibitors; D004268:DNA-Binding Proteins; D050778:NFATC Transcription Factors; D009687:Nuclear Proteins; D014157:Transcription Factors